Key facts
- This page summarizes Yaron Gilboa's Form 3 filing for Turbogen Ltd. (TRBG).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 31 Aug 2026, 08:12.
Yaron Gilboa - 28 Aug 2026 Form 3 Insider Report for Turbogen Ltd. (TRBG)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- TRBG
- Reported as of
- 28 Aug 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Yaron Gilboa
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Yaron Gilboa filed Form 3 for Turbogen Ltd. (TRBG) on 31 Aug 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002122664
Primary reporting owner
Gilboa Yaron
- Relationship
- Chief Executive Officer
- Address
- 22 EFAL STREET, KIRYAT ARYEH, PETAH TIKVA, ISRAEL
- Signature
- /s/ Yaron Gilboa
- Signature date
- 31 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TRBG
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 683,906
- Date
- 28 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 335,497
- Exercise price
- $1.39
- Footnotes
- F2, F3
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 51,634
- Exercise price
- $1.29
- Footnotes
- F4, F5
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 131,225
- Exercise price
- $3.50
- Footnotes
- F6, F7
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 401,063
- Exercise price
- $1.79
- Footnotes
- F8, F9
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 398,076
- Exercise price
- $3.39
- Footnotes
- F10, F11
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 165,000
- Exercise price
- $6.18
- Footnotes
- F12, F13
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 13 footnotes
Footnote F1
Represents (i) 375,590 ordinary shares, no par value per share, (ii) 143,316 restricted share units ("RSUs") granted on November 26, 2025, 83.3% of which vested and the remaining 16.6% vest in equal quarterly installments of 8.3% thereafter, of which 119,428 RSUs have vested and 23,888 remain unvested as of August 25, 2026; and (iii) 165,000 RSUs granted on April 29, 2026, 41.6% of which and vested and the remaining 58.3% vest in equal quarterly installments of 8.33% thereafter, of which 68,750 RSUs have vested and 96,250 remain unvested as of August 25, 2026. Each RSU represents the right to receive one ordinary share.
Footnote F2
A total of 33,300 options were granted on December 10, 2019 and vested in equal quarterly installments of 6.25% retroactively beginning on June 1, 2018. As of August 25, 2026, 33,300 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F3
The options were granted with an exercise price of NIS 4.16 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $1.39 per share.
Footnote F4
A total of 5,125 options were granted on January 3, 2021 and were fully vested on the date of grant. As of August 25, 2026, 5,125 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F5
The options were granted with an exercise price of NIS 3.86 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $1.29 per share.
Footnote F6
A total of 130,248 options were granted on January 26, 2023 and vested in equal quarterly installments of 8.3% retroactively beginning on December 31, 2021. As of August 25, 2026, 130,248 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F7
The options were granted with an exercise price of NIS 10.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $3.50 per share.
Footnote F8
A total of 398,076 options were granted on December 31, 2023 and vested in equal quarterly installments of 8.3% retroactively beginning on December 31, 2022. As of August 25, 2026, 398,076 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F9
The options were granted with an exercise price of NIS 5.38 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $1.79 per share.
Footnote F10
A total of 398,076 options were granted on November 26, 2025 and vested in equal quarterly installments of 8.3% retroactively beginning on December 31, 2023. As of August 25, 2026, 331,730 options are fully vested and none have been exercised into ordinary shares.
Footnote F11
The options were granted with an exercise price of NIS 10.16 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $3.39 per share.
Footnote F12
A total of 165,000 options were granted on April 29, 2026 and vested as follows: 33.3% vested on April 1, 2026, and the remaining 66.7% vest in equal quarterly installments of approximately 8.33% of the original grant beginning July 1, 2026. As of August 25, 2026, 68,750 options are fully vested and none have been exercised into ordinary shares.
Footnote F13
The options were granted with an exercise price of NIS 18.5 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $6.18 per share.